ClinicalTrials.Veeva

Menu

Artificial Intelligence to Predict Surgical Outcomes and Assess Pain Neuromodulation in Trigeminal Neuralgia Subjects

S

San Donato Group (GSD)

Status

Enrolling

Conditions

Artificial Intelligence
Trigeminal Nerve Diseases
Radiosurgery
Trigeminal Neuralgia
Virtual Reality
Magnetic Resonance Imaging

Treatments

Procedure: Control Group
Procedure: GKRS-VR training

Study type

Interventional

Funder types

Other

Identifiers

NCT05810428
GR-2021-12374601

Details and patient eligibility

About

Trigeminal neuralgia (TN) is the most common cause of facial pain. Medical treatment is the first therapeutic choice whereas surgery, including Gamma Knife radiosurgery (GKRS), is indicated in case of pharmacological therapy failure. However, about 20% of subjects lack adequate pain relief after surgery. Virtual reality (VR) technology has been explored as a novel tool for reducing pain perception and might be the breakthrough in treatment-resistant cases. The investigators will conduct a prospective randomized comparative study to detect the effectiveness of GKRS aided by VR-training vs GKRS alone in TN patients. In addition, using MRI and artificial intelligence (AI), the investigators will identify pre-treatment abnormalities of central nervous system circuits associated with pain to predict response to treatment. The investigators expect that brain-based biomarkers, with clinical features, will provide key information in the personalization of treatment options and bring a huge impact in the management and understanding of pain in TN.

Enrollment

50 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • diagnosis of TN according to the International Classification of Headache Disorders, third edition (ICHD-3) criteria;
  • age >18 years;
  • indication to undergo radiosurgical treatment;
  • willingness and ability to comply with scheduled visits and other trial procedures.

Exclusion criteria

  • Any person unable to lie still within the environment of the MRI scanner for the required period to perform the study and those where MRI scanning is contraindicated;
  • metal implants, pacemaker, etc.;
  • Pregnancy or breastfeeding;
  • Any significant psychiatric disease;
  • Use of illicit drugs;
  • Brain pathology shown by brain MRI and/or neurophysiological examination;
  • Any person unable to understand and follow the instructions of the investigators;
  • Any other condition according to the Investigator would make the subject unsuitable for the study.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

50 participants in 3 patient groups

GKRS-VR training
Experimental group
Description:
GKRS-VR group will undergo GKRS and neuromodulation based on Virtual Reality sensorimotor rehabilitation using an immersive system
Treatment:
Procedure: GKRS-VR training
Control Group
Active Comparator group
Description:
Control group (CT) will undergo only GKRS
Treatment:
Procedure: Control Group
Healthy subjects
No Intervention group
Description:
Age- and sex-matched healthy subjects recruited to compare neuropsychological,clinical and structural/functional magnetic resonance imaging characteristics at baseline.

Trial contacts and locations

1

Loading...

Central trial contact

Massimo Filippi, MD; Silvia Basaia, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems